Related content

Variations in ¹²³I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: a need for standardisation and validation

By Verberne Hein   Habraken Jan   Eck-Smit Berthe   Agostini Denis   Jacobson Arnold  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, Iss. 3, 2008-03 ,pp. : 547-553

Springer Publishing Company

Access to resources Recommend Favorite

Can cardiac iodine-123 metaiodobenzylguanidine imaging contribute to risk stratification in heart failure patients?

By Bax Jeroen   Boogers Mark   Henneman Maureen  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, Iss. 3, 2008-03 ,pp. : 532-534

Springer Publishing Company

Access to resources Recommend Favorite

Usefulness of ¹²³I-metaiodobenzylguanidine myocardial scintigraphy for predicting the effectiveness of β-blockers in patients with dilated cardiomyopathy from the standpoint of long-term prognosis

By Fujimoto Shinichiro   Inoue Aritomo   Hisatake Shinji   Yamashina Shohei   Yamashina Hisayo   Nakano Hajime   Yamazaki Junichi  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, Iss. 10, 2004-10 ,pp. : 1356-1361

Springer Publishing Company

Access to resources Recommend Favorite

Significance of I-123 metaiodobenzylguanidine (¹²³I-MIBG) lung activity in subjects with heart failure in comparison to healthy control subjects

By Gerson Myron   Dwivedi Alok   Abdallah Mouhamad   Shukla Rakesh   Jacobson Arnold  

Journal of Nuclear Cardiology, Vol. 20, Iss. 4, 2013-08 ,pp. : 592-599

Springer Publishing Company

Access to resources Recommend Favorite

Feasibility of [¹²³I]-meta-iodobenzylguanidine dynamic 3-D kinetic analysis in vivo using a CZT ultrafast camera: preliminary results

By Tinti Erica   Positano Vincenzo   Giorgetti Assuero   Marzullo Paolo  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 41, Iss. 1, 2014-01 ,pp. : 167-173

Springer Publishing Company

Access to resources Recommend Favorite